We are live on ! Find out more
FSA

Fort Sheridan Advisors Portfolio holdings

AUM $828M
1-Year Est. Return 26.67%
This Fund
S&P 500
This Quarter Est. Return
+11.9%
1 Year Est. Return
+26.67%
3 Year Est. Return
+87.15%
5 Year Est. Return
+109.16%
10 Year Est. Return
AUM
$347M
AUM Growth
+$41M
Cap. Flow
+$10.1M
Cap. Flow %
2.91%
Top 10 Hldgs %
48.56%
Holding
214
New
19
Increased
76
Reduced
46
Closed
14

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$2.33M
2
MTTR
Matterport, Inc. Class A Common Stock
MTTR
+$1.51M
3
AMZN icon
Amazon
AMZN
+$1.23M
4
AAPL icon
Apple
AAPL
+$838K
5
ENB icon
Enbridge
ENB
+$711K

Top Sells

Rank Stock Value
1
JMP
JMP Group LLC
JMP
+$460K
2
BABA icon
Alibaba
BABA
+$378K
3
LRCX icon
Lam Research
LRCX
+$328K
4
BIIB icon
Biogen
BIIB
+$311K
5
HD icon
Home Depot
HD
+$304K

Sector Composition

Rank Sector Weight
1 Financials 27.32%
2 Technology 26.07%
3 Healthcare 9.27%
4 Energy 7.49%
5 Communication Services 5.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KWR icon
176
Quaker Houghton
KWR
$2.89B
$208K 0.06%
900
NKE icon
177
Nike
NKE
$63.3B
$205K 0.06%
+1,228
New +$203K
FMBI
178
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$205K 0.06%
10,000
AON icon
179
Aon
AON
$75.9B
$203K 0.06%
+675
New +$202K
BEPC icon
180
Brookfield Renewable
BEPC
$6.34B
$201K 0.06%
5,446
NLY icon
181
Annaly Capital Management
NLY
$17.2B
$187K 0.05%
5,983
+194
+3% +$6.52K
ONB icon
182
Old National Bancorp
ONB
$10.3B
$181K 0.05%
10,000
FCEL icon
183
FuelCell Energy
FCEL
$1.71B
$178K 0.05%
+1,142
New +$269K
BDJ icon
184
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.73B
$132K 0.04%
13,100
LCTX icon
185
Lineage Cell Therapeutics
LCTX
$277M
$130K 0.04%
52,931
+5,000
+10% +$11.7K
VISN
186
Vistance Networks Inc
VISN
$2.72B
$125K 0.04%
11,299
-58
-0.5% -$636
OFS icon
187
OFS Capital
OFS
$46.4M
$112K 0.03%
10,270
YPF icon
188
YPF
YPF
$20B
$92K 0.03%
23,975
TWO
189
Two Harbors Investment
TWO
$1.27B
$82K 0.02%
3,555
GERN icon
190
Geron
GERN
$821M
$38K 0.01%
31,500
MUX icon
191
McEwen Inc
MUX
$1.07B
$27K 0.01%
+3,015
New +$31.4K
EQD.WS
192
DELISTED
Equity Distribution Acquisition Corp. Warrants, each whole warrant exercisable for one share of Clas
EQD.WS
$7K ﹤0.01%
10,000
-100
-1% -$87
BABA icon
193
Alibaba
BABA
$305B
-2,550
Closed -$378K
BIIB icon
194
Biogen
BIIB
$29.8B
-1,100
Closed -$311K
DFJ icon
195
WisdomTree Japan SmallCap Dividend Fund
DFJ
$383M
-2,870
Closed -$221K
LCID icon
196
Lucid Motors
LCID
$3B
-1,090
Closed -$277K
MRNA icon
197
Moderna
MRNA
$22B
-623
Closed -$240K
RCS
198
PIMCO Strategic Income Fund
RCS
$248M
-32,000
Closed -$226K
REGN icon
199
Regeneron Pharmaceuticals
REGN
$78.2B
-345
Closed -$209K
RGNX icon
200
Regenxbio
RGNX
$638M
-5,253
Closed -$220K

Similar funds

Fort Sheridan Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Fort Sheridan Advisors held 214 positions worth $347M, up 13% from $306M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Fort Sheridan Advisors's Q4 2021 filing shows 19 new, 76 increased, 46 reduced and 14 closed positions. Its largest new stake was Matterport, Inc. Class A Common Stock: 65,800 shares worth $1.36M. The largest sale was JMP Group LLC, an estimated $460K.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

  • Fort Sheridan Advisors's largest Q4 2021 buy was Matterport, Inc. Class A Common Stock: 65,800 shares worth $1.36M.
  • Fort Sheridan Advisors added most to CME Group in Q4 2021, an estimated $2.33M increase.
  • Fort Sheridan Advisors's biggest Q4 2021 reduction was Lam Research, cutting an estimated $328K.
  • Fort Sheridan Advisors fully exited JMP Group LLC in Q4 2021, selling an estimated $460K.
  • Fort Sheridan Advisors's ten largest holdings make up 49% of its $347M portfolio in Q4 2021.
  • Fort Sheridan Advisors opened 19 new positions and closed 14 in Q4 2021.
  • Fort Sheridan Advisors's portfolio value rose 13% quarter-over-quarter to $347M.

Based on Fort Sheridan Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.